Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 2
2003 3
2004 4
2005 3
2006 4
2007 6
2008 6
2009 4
2010 4
2011 6
2012 5
2013 8
2014 7
2015 13
2016 12
2017 2
2018 2
2020 2
2021 1
2022 1
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial.
Danese S, Panaccione R, Feagan BG, Afzali A, Rubin DT, Sands BE, Reinisch W, Panés J, Sahoo A, Terry NA, Chan D, Han C, Frustaci ME, Yang Z, Sandborn WJ, Hisamatsu T, Andrews JM, D'Haens GR; GALAXI-1 Study Group. Danese S, et al. Lancet Gastroenterol Hepatol. 2024 Feb;9(2):133-146. doi: 10.1016/S2468-1253(23)00318-7. Epub 2023 Dec 14. Lancet Gastroenterol Hepatol. 2024. PMID: 38104569 Clinical Trial.
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis.
Akhlaghpour M, Haritunians T, More SK, Thomas LS, Stamps DT, Dube S, Li D, Yang S, Landers CJ, Mengesha E, Hamade H, Murali R, Potdar AA, Wolf AJ, Botwin GJ, Khrom M; International IBD Genetics Consortium; Ananthakrishnan AN, Faubion WA, Jabri B, Lira SA, Newberry RD, Sandler RS, Sartor RB, Xavier RJ, Brant SR, Cho JH, Duerr RH, Lazarev MG, Rioux JD, Schumm LP, Silverberg MS, Zaghiyan K, Fleshner P, Melmed GY, Vasiliauskas EA, Ha C, Rabizadeh S, Syal G, Bonthala NN, Ziring DA, Targan SR, Long MD, McGovern DPB, Michelsen KS. Akhlaghpour M, et al. Gut. 2023 Nov;72(11):2068-2080. doi: 10.1136/gutjnl-2023-329689. Epub 2023 Apr 20. Gut. 2023. PMID: 37080587 Free article.
[Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease].
Teich N, Ludewig C, Schmelz R, Bästlein EC, Geißler S, Nagl S, Walldorf J, Krause T, Maaser C, Mohl W, Wedemeyer HH, Bauer T, Büning C, Grunert P, Hasselblatt P, Hänschen M, Kahl M, Engelke O, Schubert S, Holler B, Streetz K, Arnim UV, Schmidt K, Stallmach A; für die German IBD Study Group; Collaborators:; Jochen Maul, Berlin; Axel Schweitzer, Münster; Wolfgang Breit, Dinkelsbühl; Jan-Hinnerk Hofer, Köln; Marc Eisold, Mössingen; Michael R. Mroß, Berlin; Stefanie Howaldt, Hamburg; Stefanie Strobl, Ingolstadt; Robert Ehehalt, Heidelberg; Klaus Schmidt, Lübeck; Carsten Triller, Heinsberg; Serhat Aymaz, Düren; Thorsten Brechmann, Bochum; Axel Dignaß, Frankfurt; Elisabeth Schnoy, Augsburg; Bernd Swarovsky, Albstadt; Dr. med. Birgit Gerhard, Berlin; Doris Zink, Nürnberg; Ulrich Finger, Berlin; Franz Josef Heil, Andernach; Gerd-Rüdiger Franke, Dinkelsbühl; Günther Böhm, Ludwigshafen; Jens Hunkemöller, Oberberg; Martin Schmidt-Lauber, Oldenburg; Mirko Vonderach, Oldenburg; Olaf Mensler, Oberberg; Rainer Kunz, Fürstenfeldbruck; Richard Kölble, Düsseldorf; Christoph Rother, Sundern; Ulf Klönne, Göttingen; Ulrich Graefe, Berlin; Wolfgang Schwarz, Hamburg; Georg Schmitz, Düren; Hans Vi… See abstract for full author list ➔ Teich N, et al. Among authors: buning c. Z Gastroenterol. 2021 Nov;59(11):1189-1196. doi: 10.1055/a-1508-6734. Epub 2021 Jul 16. Z Gastroenterol. 2021. PMID: 34748206 German.
Thumb sucking or nail biting in childhood and adolescence is associated with an increased risk of Crohn's disease: results from a large case-control study.
Teich N, Mohl W, Primas C, Novacek G, Gauss A, Walldorf J, Felten G, Atreya R, Kruis W, Bettenworth D, Roznowski AB, Langhorst J, Schmidt K, Bruns T, Stallmach A; German IBD Study Group. Teich N, et al. Scand J Gastroenterol. 2020 Sep;55(9):1028-1034. doi: 10.1080/00365521.2020.1797869. Epub 2020 Jul 30. Scand J Gastroenterol. 2020. PMID: 32730708
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes.
Momozawa Y, Dmitrieva J, Théâtre E, Deffontaine V, Rahmouni S, Charloteaux B, Crins F, Docampo E, Elansary M, Gori AS, Lecut C, Mariman R, Mni M, Oury C, Altukhov I, Alexeev D, Aulchenko Y, Amininejad L, Bouma G, Hoentjen F, Löwenberg M, Oldenburg B, Pierik MJ, Vander Meulen-de Jong AE, Janneke van der Woude C, Visschedijk MC; International IBD Genetics Consortium; Lathrop M, Hugot JP, Weersma RK, De Vos M, Franchimont D, Vermeire S, Kubo M, Louis E, Georges M. Momozawa Y, et al. Nat Commun. 2018 Jun 21;9(1):2427. doi: 10.1038/s41467-018-04365-8. Nat Commun. 2018. PMID: 29930244 Free PMC article.
Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitis.
Bär F, Kühbacher T, Dietrich NA, Krause T, Stallmach A, Teich N, Schreiber S, Walldorf J, Schmelz R, Büning C, Fellermann K, Büning J, Helwig U; German IBD Study Group. Bär F, et al. Among authors: buning c. Aliment Pharmacol Ther. 2018 Mar;47(5):581-587. doi: 10.1111/apt.14479. Epub 2017 Dec 19. Aliment Pharmacol Ther. 2018. PMID: 29266360
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group. Feagan BG, et al. N Engl J Med. 2016 Nov 17;375(20):1946-1960. doi: 10.1056/NEJMoa1602773. N Engl J Med. 2016. PMID: 27959607 Free article. Clinical Trial.
86 results